サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409579

低比重リポ蛋白検査の世界市場レポート 2024年

Low-Density Lipoprotein Test Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
低比重リポ蛋白検査の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

低比重リポ蛋白検査の市場規模は近年着実に成長しています。2023年の81億1,000万米ドルから2024年には84億6,000万米ドルへと、CAGR4.3％で拡大します。過去に観察された成長は、心血管医学研究の進歩、心臓の健康に対する意識の高まり、治療パラダイムの転換、臨床ガイドラインや推奨事項の遵守、予防ヘルスケアの重視などの要因によるものです。

低比重リポ蛋白検査の市場規模は、今後数年間で安定した成長が見込まれます。2028年の年間平均成長率（CAGR）は4.9％で、102億4,000万米ドルに成長します。予測期間中に予想される成長の要因としては、ヘルスケア支出の増加、高齢化に伴う人口動態の変化、心血管疾患の負担増、個別化医療へのシフト、ヘルスケア政策やガイドラインの影響などが挙げられます。予測期間に予想される主な動向には、心血管疾患の有病率の上昇、予防ヘルスケアの重視、個別化医療と治療アプローチの採用、健康意識と教育の重視、規制ガイドラインと勧告の影響などがあります。

予測される心血管疾患の有病率の増加は、低比重リポ蛋白検査市場の成長を促進すると考えられます。心血管疾患には心臓や血管に影響を及ぼす疾患が含まれ、LDL検査は低比重リポ蛋白レベルを直接測定することで、これらの疾患の管理に重要な役割を果たしています。例えば、2022年10月現在、米国疾病予防管理センター（CDC）は、心臓病が性別やほとんどの人種・民族を問わず米国における死亡原因の第1位であると報告しています。心臓病は2021年に米国で約695,000人の命を奪い、死亡者の5人に1人を占めました。最も有病率の高い冠動脈性心疾患では、2020年に375,476人が死亡しました。したがって、心血管疾患の急増が低比重リポ蛋白検査市場拡大の原動力となっています。

肥満の増加は低比重リポ蛋白検査市場の成長を促進すると予想されます。肥満は、過剰な体脂肪蓄積と体格指数（BMI）30以上を特徴とし、多くの健康リスクと関連しています。低比重リポ蛋白（LDL）検査は、肥満に罹患した人のLDLコレステロール値を測定するのに役立ちます。例えば、世界保健機関（WHO）の2022年3月の報告書によると、世界全体で10億人以上が肥満と闘っており、その内訳は成人6億5,000万人、青年3億4,000万人、小児3,900万人で、これらの数は増加傾向にあります。さらに、約1億6,700万人が過体重または肥満のために健康を損なう可能性があると推定されています。したがって、肥満の有病率の増加が低比重リポ蛋白検査市場の成長を促進しています。

2023年の低比重リポ蛋白検査市場で最大の地域は北米でした。低比重リポ蛋白検査市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 低比重リポ蛋白検査市場の特徴

第3章 低比重リポ蛋白検査市場の動向と戦略

第4章 低比重リポ蛋白検査市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の低比重リポ蛋白検査市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 低比重リポ蛋白検査市場セグメンテーション

  • 世界の低比重リポ蛋白検査市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • LDL-C
  • LDL-P
  • LDL-B
  • その他の製品
  • 世界の低比重リポ蛋白検査市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • キット
  • 試薬
  • デバイス
  • その他のコンポーネント
  • 世界の低比重リポ蛋白検査市場、疾患タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 糖尿病
  • 脳卒中
  • アテローム性動脈硬化症
  • 肥満
  • 脂質異常症
  • 頸動脈疾患
  • 末梢動脈疾患
  • 狭心症
  • 他の種類の病気
  • 世界の低比重リポ蛋白検査市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 直接入札
  • 小売り
  • 世界の低比重リポ蛋白検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • 外来診療
  • 研究
  • その他のエンドユーザー

第7章 低比重リポ蛋白検査市場の地域および国分析

  • 世界の低比重リポ蛋白検査市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の低比重リポ蛋白検査市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋の低比重リポ蛋白検査市場

第9章 中国の低比重リポ蛋白検査市場

第10章 インドの低比重リポ蛋白検査市場

第11章 日本の低比重リポ蛋白検査市場

第12章 オーストラリアの低比重リポ蛋白検査市場

第13章 インドネシアの低比重リポ蛋白検査市場

第14章 韓国の低比重リポ蛋白検査市場

第15章 西欧の低比重リポ蛋白検査市場

第16章 英国の低比重リポ蛋白検査市場

第17章 ドイツの低比重リポ蛋白検査市場

第18章 フランスの低比重リポ蛋白検査市場

第19章 イタリアの低比重リポ蛋白検査市場

第20章 スペインの低比重リポ蛋白検査市場

第21章 東欧の低比重リポ蛋白検査市場

第22章 ロシアの低比重リポ蛋白検査市場

第23章 北米の低比重リポ蛋白検査市場

第24章 米国の低比重リポ蛋白検査市場

第25章 カナダの低比重リポ蛋白検査市場

第26章 南米の低比重リポ蛋白検査市場

第27章 ブラジルの低比重リポ蛋白検査市場

第28章 中東の低比重リポ蛋白検査市場

第29章 アフリカの低比重リポ蛋白検査市場

第30章 低比重リポ蛋白検査市場の競合情勢と企業プロファイル

  • 低比重リポ蛋白検査市場の競合情勢
  • 低比重リポ蛋白検査市場の企業プロファイル
    • Abbott Laboratories
    • Qiagen NV
    • Randox Laboratories Ltd.
    • Eurofins Scientific SE
    • Danaher Corporation

第31章 世界の低比重リポ蛋白検査市場の競合ベンチマーキング

第32章 世界の低比重リポ蛋白検査市場競争力ダッシュボード

第33章 低比重リポ蛋白検査市場における主要な合併と買収

第34章 低比重リポ蛋白検査市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11117

“Low-Density Lipoprotein Test Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on low-density lipoprotein test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for low-density lipoprotein test? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The low-density lipoprotein test market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: LDL-C; LDL-P; LDL-B; Other Products
  • 2) By Component: Kits; Reagents; Devices; Other Components
  • 3) By Disease Type: Diabetes; Stroke; Atherosclerosis; Obesity; Dyslipidaemia; Carotid Artery Disease; Peripheral Arterial Disease; Angina; Other Disease Types
  • 4) By Distribution Channel: Direct Tenders; Retail
  • 5) By End User: Hospitals; Clinics; Ambulatory Care; Research Laboratory; Other End Users
  • Companies Mentioned: Abbott Laboratories; Qiagen N.V.; Randox Laboratories Ltd.; Eurofins Scientific SE; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The low-density lipoprotein (LDL) test is a blood test employed by doctors to measure a patient's levels of LDL cholesterol in the bloodstream. This testing can evaluate LDL levels independently or as part of a lipid panel test, offering insights into the accumulation of cholesterol in the arteries, which can contribute to heart attacks and strokes.

The primary product types of low-density lipoprotein tests include LDL-C, LDL-P, LDL-B, and other related products. Low-density lipoprotein cholesterol (LDL-C), commonly known as 'bad cholesterol,' tends to accumulate in the walls of blood vessels, increasing the risk of health issues such as heart attacks or strokes. The components used in these tests include kits, reagents, devices, and other related components. These tests find applications in various health conditions such as diabetes, stroke, atherosclerosis, obesity, dyslipidemia, carotid artery disease, peripheral arterial disease, angina, among others. Distribution channels encompass direct tenders and retail outlets, with usage prevalent in hospitals, clinics, ambulatory care centers, research laboratories, and other healthcare settings.

The low-density lipoprotein test market research report is one of a series of new reports from The Business Research Company that provides low-density lipoprotein test market statistics, including low-density lipoprotein test industry global market size, regional shares, competitors with a low-density lipoprotein test market share, detailed low-density lipoprotein test market segments, market trends and opportunities, and any further data you may need to thrive in the low-density lipoprotein test industry. This low-density lipoprotein test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.11 billion in 2023 to $8.46 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth observed in the historical period can be attributed to factors such as advancements in cardiovascular medicine research, increased awareness of heart health, shifts in treatment paradigms, adherence to clinical guidelines and recommendations, and an emphasis on preventive healthcare.

The low-density lipoprotein test market size is expected to see steady growth in the next few years. It will grow to $10.24 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The anticipated growth in the forecast period can be attributed to factors such as increasing healthcare expenditure, demographic changes with an aging population, a rise in the burden of cardiovascular diseases, a shift towards personalized medicine, and the influence of healthcare policy and guidelines. Major trends expected in the forecast period include the rising prevalence of cardiovascular diseases, an emphasis on preventive healthcare, the adoption of personalized medicine and treatment approaches, a focus on health awareness and education, and the impact of regulatory guidelines and recommendations.

The anticipated increase in the prevalence of cardiovascular diseases is set to drive the growth of the low-density lipoprotein test market. Cardiovascular diseases encompass conditions affecting the heart or blood vessels, and the LDL test plays a crucial role in managing these diseases by directly measuring low-density lipoprotein levels. For example, as of October 2022, the Centers for Disease Control and Prevention (CDC) reported that heart disease ranks as the leading cause of mortality in the United States across genders and most racial and ethnic groups. Heart disease claimed nearly 695,000 lives in the United States in 2021, accounting for one in every five deaths. The most prevalent type, coronary heart disease, resulted in 375,476 deaths in 2020. Hence, the surge in cardiovascular diseases is a driving force behind the expansion of the low-density lipoprotein test market.

The increasing prevalence of obesity is expected to fuel the growth of the low-density lipoprotein test market. Obesity, characterized by excessive body fat accumulation and a body mass index (BMI) of 30 or higher, is associated with numerous health risks. The low-density lipoprotein (LDL) test is instrumental in measuring LDL cholesterol levels in individuals affected by obesity. For instance, according to the World Health Organization's March 2022 report, over 1 billion individuals globally grapple with obesity, comprising 650 million adults, 340 million adolescents, and 39 million children, with these numbers on the rise. Additionally, it is estimated that around 167 million people are poised to experience compromised health due to being overweight or obese. Therefore, the increasing prevalence of obesity is propelling the growth of the low-density lipoprotein test market.

Product innovations are emerging as a key trend in the low-density lipoprotein test market, with major companies introducing innovative products to maintain their market position. In December 2021, Novartis AG, a Switzerland-based pharmaceutical giant, launched Leqvio (Inclisiran), a groundbreaking siRNA therapy designed to lower low-density lipoprotein cholesterol effectively. This medication offers sustained reductions in LDL cholesterol and requires only two maintenance doses annually. For certain patients with atherosclerotic cardiovascular disease (ASCVD) receiving maximally tolerated statin therapy, Leqvio delivers a substantial and long-lasting LDL cholesterol decrease of up to 52% compared to a placebo. This innovative approach opens new possibilities for impacting cardiovascular disease within healthcare systems.

Major companies in the low-density lipoprotein test market are strategically focusing on developing innovations such as homogenous assays to gain a competitive edge. A homogenous assay is an immunoassay type that does not necessitate a separation step to measure analyte concentration. For example, in May 2021, DiaSys Diagnostic Systems GmbH, a US-based developer of clinical diagnostic equipment, launched LDL-c direct FS, a homogenous assay for directly determining LDL cholesterol levels. This fast, accurate, and reliable assay employs a block-polymer-based approach, offering extended stability and low calibration frequency. It is compatible with all automated clinical chemical analyzers and exhibits strong compatibility with commercially available techniques for measuring low-density lipoprotein.

In February 2023, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, completed the acquisition of CinCor Pharma Inc. for an undisclosed amount. This strategic move is expected to bolster AstraZeneca's cardiorenal pipeline, expanding it with Baxdrostat, a novel aldosterone synthase inhibitor (ASI). CinCor Pharma Inc., a US-based clinical-last biotechnology company, specializes in developing therapies for lowering LDL hypertension.

Major companies operating in the low-density lipoprotein test market report are Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., Lincoln Diagnostics LLC, DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Siemens AG, Alfa Wassermann Inc., Laboratory Corporation of America Holdings, Merck KGaA, F Hoffmann-La Roche Ltd., Agilent Technologies Inc., BioVision Incorporated, Abcam plc, BioAssay Systems, BioChain Institute Inc., BioLegend Inc., Bioo Scientific LLC, Enzo Life Sciences Inc., GenScript Biotech Corporation .

North America was the largest region in the Low-Density Lipoprotein Test market in 2023. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the low-density lipoprotein test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The low-density lipoprotein test market includes revenues earned by entities by measuring very low-density lipoprotein (VLDL) testing and ultra low-density lipoprotein (ULDL) testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Low-Density Lipoprotein Test Market Characteristics

3. Low-Density Lipoprotein Test Market Trends And Strategies

4. Low-Density Lipoprotein Test Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Low-Density Lipoprotein Test Market Size and Growth

  • 5.1. Global Low-Density Lipoprotein Test Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Low-Density Lipoprotein Test Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Low-Density Lipoprotein Test Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Low-Density Lipoprotein Test Market Segmentation

  • 6.1. Global Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • LDL-C
  • LDL-P
  • LDL-B
  • Other Products
  • 6.2. Global Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kits
  • Reagents
  • Devices
  • Other Components
  • 6.3. Global Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diabetes
  • Stroke
  • Atherosclerosis
  • Obesity
  • Dyslipidaemia
  • Carotid Artery Disease
  • Peripheral Arterial Disease
  • Angina
  • Other Disease Types
  • 6.4. Global Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Direct Tenders
  • Retail
  • 6.5. Global Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Care
  • Research Laboratory
  • Other End Users

7. Low-Density Lipoprotein Test Market Regional And Country Analysis

  • 7.1. Global Low-Density Lipoprotein Test Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Low-Density Lipoprotein Test Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Low-Density Lipoprotein Test Market

  • 8.1. Asia-Pacific Low-Density Lipoprotein Test Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Low-Density Lipoprotein Test Market

  • 9.1. China Low-Density Lipoprotein Test Market Overview
  • 9.2. China Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Low-Density Lipoprotein Test Market

  • 10.1. India Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Low-Density Lipoprotein Test Market

  • 11.1. Japan Low-Density Lipoprotein Test Market Overview
  • 11.2. Japan Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Low-Density Lipoprotein Test Market

  • 12.1. Australia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Low-Density Lipoprotein Test Market

  • 13.1. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Low-Density Lipoprotein Test Market

  • 14.1. South Korea Low-Density Lipoprotein Test Market Overview
  • 14.2. South Korea Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Low-Density Lipoprotein Test Market

  • 15.1. Western Europe Low-Density Lipoprotein Test Market Overview
  • 15.2. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Low-Density Lipoprotein Test Market

  • 16.1. UK Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Low-Density Lipoprotein Test Market

  • 17.1. Germany Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Low-Density Lipoprotein Test Market

  • 18.1. France Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Low-Density Lipoprotein Test Market

  • 19.1. Italy Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Low-Density Lipoprotein Test Market

  • 20.1. Spain Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Low-Density Lipoprotein Test Market

  • 21.1. Eastern Europe Low-Density Lipoprotein Test Market Overview
  • 21.2. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Low-Density Lipoprotein Test Market

  • 22.1. Russia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Low-Density Lipoprotein Test Market

  • 23.1. North America Low-Density Lipoprotein Test Market Overview
  • 23.2. North America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Low-Density Lipoprotein Test Market

  • 24.1. USA Low-Density Lipoprotein Test Market Overview
  • 24.2. USA Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Low-Density Lipoprotein Test Market

  • 25.1. Canada Low-Density Lipoprotein Test Market Overview
  • 25.2. Canada Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Low-Density Lipoprotein Test Market

  • 26.1. South America Low-Density Lipoprotein Test Market Overview
  • 26.2. South America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Low-Density Lipoprotein Test Market

  • 27.1. Brazil Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Low-Density Lipoprotein Test Market

  • 28.1. Middle East Low-Density Lipoprotein Test Market Overview
  • 28.2. Middle East Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Low-Density Lipoprotein Test Market

  • 29.1. Africa Low-Density Lipoprotein Test Market Overview
  • 29.2. Africa Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Low-Density Lipoprotein Test Market Competitive Landscape And Company Profiles

  • 30.1. Low-Density Lipoprotein Test Market Competitive Landscape
  • 30.2. Low-Density Lipoprotein Test Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Qiagen N.V.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Randox Laboratories Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific SE
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Low-Density Lipoprotein Test Market Competitive Benchmarking

32. Global Low-Density Lipoprotein Test Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Low-Density Lipoprotein Test Market

34. Low-Density Lipoprotein Test Market Future Outlook and Potential Analysis

  • 34.1 Low-Density Lipoprotein Test Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Low-Density Lipoprotein Test Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Low-Density Lipoprotein Test Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer